Eibenschutz, L.;                     Caputo, S.;                     Camera, E.;                     Carbone, A.;                     Silipo, V.;                     Migliano, E.;                     Aurizi, C.;                     Cota, C.;                     Frascione, P.;                     Bellei, B.    
        Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts? Cancers 2021, 13, 5858.
    https://doi.org/10.3390/cancers13225858
    AMA Style
    
                                Eibenschutz L,                                 Caputo S,                                 Camera E,                                 Carbone A,                                 Silipo V,                                 Migliano E,                                 Aurizi C,                                 Cota C,                                 Frascione P,                                 Bellei B.        
                Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts? Cancers. 2021; 13(22):5858.
        https://doi.org/10.3390/cancers13225858
    
    Chicago/Turabian Style
    
                                Eibenschutz, Laura,                                 Silvia Caputo,                                 Emanuela Camera,                                 Anna Carbone,                                 Vitaliano Silipo,                                 Emilia Migliano,                                 Caterina Aurizi,                                 Carlo Cota,                                 Pasquale Frascione,                                 and Barbara Bellei.        
                2021. "Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts?" Cancers 13, no. 22: 5858.
        https://doi.org/10.3390/cancers13225858
    
    APA Style
    
                                Eibenschutz, L.,                                 Caputo, S.,                                 Camera, E.,                                 Carbone, A.,                                 Silipo, V.,                                 Migliano, E.,                                 Aurizi, C.,                                 Cota, C.,                                 Frascione, P.,                                 & Bellei, B.        
        
        (2021). Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts? Cancers, 13(22), 5858.
        https://doi.org/10.3390/cancers13225858